IP Library › Granted Patent US 11,521,444
Granted Patent B1
US 11,521,444 · App. 17/739,756 · Granted Dec 6, 2022

Smart storage system

Inventors: Yale Badik (Madison, CT); Deanna Felker (West Hills, CA)
Assignee: KURE, LLC
G07C9/00563G07C9/00571G07C9/00912G16H20/13H04L63/083H04L63/0861
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,521,444
App. No.
17/739,756
Granted
Dec 6, 2022
Kind
B1
Abstract

Embodiments relate to a system comprising a drug storage comprising a container to hold a drug; a communication module; and a cyber security module. The system is operable to log record of an access of the drug and maintain a ledger of the record of the access of the drug using a blockchain technology. The access of the drug is secured by the cyber security module.

Claims (77)

1. A system comprising:

a drug storage comprising a container to hold a drug container comprising a drug;

a processor;

a memory; wherein the processor is communicatively coupled with the memory;

a communication module; and

a cyber security module;

and wherein the processor is operable to:

log record of an access of the drug container, and

maintain a ledger of the record of the access of the drug container using a blockchain technology; and

wherein the system is secured through the cyber security module.

2. The system of claim 1 , wherein the system further comprises:

an input interface;

an output interface;

a camera;

wherein the processor is communicatively coupled with the memory; and

wherein the processor is operable to receive through the input interface, a unique identity, and a biometric identification of a user; wherein the unique identity of the user comprises at least one of a unique identification number, an RFID tag, a password, and an unlocking pattern; and

wherein the biometric identification of the user comprises at least one of a fingerprint, an eyeblink, a retina scan, an iris scan, a facial image scan and an eye scan.

3. The system of claim 2 , wherein the drug storage further comprises:

a lock associated with the container;

a receptacle having at least a first sensor to detect the access of the drug container; and

wherein the lock and the first sensor are communicatively coupled with the processor of the system to selectively activate and deactivate the lock.

4. The system of claim 3 , wherein the drug storage comprises a cover to the container; and wherein the cover comprises at least one of a lid, a door, a hinged cover, a magnetic cover, and a sliding door.

5. The system of claim 3 , wherein the system is in communication with a server through the communication module; and wherein the server comprises a database.

6. The system of claim 3 , wherein the lock is activated by a second level of authentication by the user.

7. The system of claim 6 , wherein the second level of authentication comprises the unique identity of the user and the biometric identification of the user.

8. The system of claim 5 , wherein the processor is operable to:

interact with the server to authenticate the user by matching credential of the unique identity with a record of practitioners and a record of patients stored in the database;

activate the lock the drug storage for the access if the credential of the unique identity does not match;

interact with the server to authenticate the user by matching a credential of the biometric identification with the record of practitioners and the record of patients stored in the database; and

activate the lock the drug storage for the access if the credential of the biometric identification does not match.

9. The system of claim 2 , wherein the access to the drug container in the drug storage is synchronized with a scheduled time to access the drug container.

10. The system of claim 3 , wherein the first sensor comprises at least one of a weight sensor, an RFID tag reader, an IR sensor, a photodiode, and an indicator tag on the drug container to detect the access of the drug container from the container.

11. The system of claim 1 , wherein the drug comprises at least one of a controlled substance, an opioid, a narcotic drug, and a psychedelic drug.

12. The system of claim 2 , wherein the log record of the access comprises: a name of drug, a time, a date, a day, a month, a year, quantity of the drug container accessed, name of the user receiving the drug container, and a quantity of drug container remaining.

13. The system of claim 5 , wherein the cyber security module further comprises an information security management module providing isolation between the system and the server.

14. The system of claim 13 , wherein the information security management module is operable to:

receive data from at least one of the input interface, the drug storage, and the database;

exchange a security key at a start of a communication between the communication module and the server;

receive the security key from the server;

authenticate an identity of the server by verifying the security key;

analyze the security key for potential cyber security threats;

negotiate an encryption key between the communication module and the server;

encrypt the data; and

transmit the encrypted data to the server in case no cyber security threat is detected.

15. The system of claim 13 , wherein the information security management module is operable to:

exchange a security key at a start of the communication between the communication module and the server

receive the security key from the server;

authenticate an identity of the server by verifying the security key;

analyze the security key for potential cyber security threats;

negotiate an encryption key between the system and the server;

receive encrypted data;

decrypt the encrypted data;

perform an integrity check of the decrypted data; and

transmit the decrypted data to at least one of output interface, the drug storage, and the database through the communication module in case no cyber security threat is detected.

16. The system of claim 15 , wherein the information security management module is operable to discard the encrypted data received if the integrity check of the encrypted data fails.

17. The system of claim 15 , wherein the information security management module is configured to check the integrity of the encrypted data by checking accuracy, consistency, and any possible data loss during the communication through the communication module.

18. The system of claim 13 , wherein the information security management modules is configured to perform asynchronous authentication and validation of the communication between the communication module and the server.

19. A method comprising steps of:

receiving an identification of a user through a system;

authenticating the user through the system;

deactivating a lock of a container of a drug storage; and

allowing the user to access a drug container;

communicating through a communication module;

logging record of access of the drug container; and

maintaining a ledger of the record of the access of the drug container using blockchain technology; and

wherein the system is secured through a cyber security module.

20. A system comprising:

an input interface;

a drug storage comprising a container to hold a drug;

a communication module; and

a cyber security module;

a processor;

a memory; wherein the processor is communicatively coupled with the memory and wherein the processor is operable to:

allow an access of the drug;

log record of the access of the drug, and

maintain a ledger of the record of the access of the drug using a blockchain technology; and

wherein the system is secured by the cyber security module.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2024
From: KURE LLC
To: CORNERSTONE INTELLECTUAL PROPERTY, LLC
Reel/Frame 066166/0274 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2022
From: BADIK, YALE; FELKER, DEANNA
To: KURE LLC
Reel/Frame 059892/0051 →
Cited By (14)
US 12,242,599 US 12,284,224 US 12,348,519 US 12,355,770 US 12,423,418 US 12,432,242 US 12,452,051 US 12,511,962 US 12,603,921 US 12,626,216 US 12,670,246 US 12,676,036 US 12,695,793 US 12,705,943